- Human Biospecimens
- For Researchers
- For Biospecimen Contributors
- For Patients
January 27, 2015
If personalized medicine will ever achieve the heights it is capable of, it needs an adequate inventory of high quality biospecimens that physicians and researchers can access with ease, speed, and confidence.
January 8, 2015
Scientists have developed a statistical model that will potentially help diagnose and treat cancer patients based on the genomic information of individual solid tumors.
While both doctors and biopharmaceutical companies are interested in the potential of personalized medicine, the pursuit of treatments within this model has proven more productive for certain classes of diseases than others.
January 7, 2015
Whether research focuses on the disease process within cells or drug discovery for more effective treatments, remnant clinical specimens or their associated data both play pivotal roles in these studies. Data show that patients agree. Specifically, 87 percent of patients believe that the donation of human biospecimens is essential, while 75 percent are willing to […]